#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rheumatoid arthritis Trigeminal neuralgia Hypersomnia Oesophageal squamous cell carcinoma Eosinophilic oesophagitis Chronic myeloid leukaemia Astrocytoma Kawasaki's disease Congenital aplastic anaemia Squamous cell carcinoma of the oral cavity Monogenic diabetes Follicular lymphoma stage I Retinopathy proliferative Glomerulonephritis Choroidal dystrophy More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Treatment CADASIL Hereditary motor and sensory neuropathy – Life with Disease Nephroblastoma – Treatment Methylmalonic acidaemia – Life with Disease Mantle cell lymphoma stage III – Trials in Disease Gaucher’s disease type I – Diagnostics Angiosarcoma metastatic – Basic Information Chondrosarcoma metastatic – Life with Disease Hereditary neuropathic amyloidosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magrolimab Dexamethasone Phosphate Idursulfase Ficlatuzumab Oxycodone Hydrochloride Mps-103 Diltiazem Hydrochloride Hydralazine Hydrochloride Naloxone Oxytocin Romiplostim CC-97540 RO7288817 Adagrasib Specific Nucleic Acid Sna-Xfsc RNK001 Mbf-015 Hepatitis B Surface Antigen Brigatinib Ace Inhibitors, Plain More therapies…

    Learn about Your Condition

    Actinic cheilitis Stomatitis Albuminuria Mastocytosis Spinal cord injury Behcet's syndrome Endotracheal intubation Cutaneous lupus erythematosus Viral myocarditis Palmoplantar pustulosis Atrial fibrillation Mitral valve disease Intracranial aneurysm Acute respiratory failure Septic shock More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaza…

Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaza

Bethesda Utca 3, Budapest, 1146, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • A Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Fenfluramine Hydrochloride
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

    Recruiting

    3 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +4

  • Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +5

  • Safety and Efficacy of Intrathecal BIIB115 in Infants with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Spinal muscular atrophy
    Investigated Drugs:
    • BIIB115
    Belgium Croatia France Germany Hungary Ireland +4

  • Study on the Long-Term Safety of Pimavanserin for Treating Irritability in Children and Adolescents with Autism Spectrum Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Pimavanserin Tartrate
    France Hungary Italy Poland Spain

  • Study on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Soticlestat
    Belgium France Germany Greece Hungary Italy +4

  • Study on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome

    Not recruiting

    2 1
    Investigated Drugs:
    • Gemlapodect
    Belgium France Germany Hungary Poland Spain

  • Study on the Safety and Effectiveness of Cenobamate for Children with Focal Seizures

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Cenobamate
    Germany Hungary Poland Spain

  • Long-Term Safety Study of Lacosamide for Children with Epilepsy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Lacosamide
    Hungary Romania

  • Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette’s Disorder

    Not recruiting

    3 1
    Investigated Diseases:
    • Tourette’s disorder
    Investigated Drugs:
    • Ecopipam Hydrochloride
    Bulgaria Denmark France Germany Hungary Italy +3
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!